Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan.

Slides:



Advertisements
Similar presentations
Pediatric CRRT: Ultrafiltration Control William E. Smoyer, M.D. Pediatric Nephrology University of Michigan.
Advertisements

Thermic Control in PCRRT Theresa A. Mottes RN Research & Dialysis Nurse C. S. Mott Childrens Hospital University of Michigan.
Regional Citrate Anticoagulation during CVVH in the
Neonatal and Infant CRRT
Norma J Maxvold Pediatric Critical Care
CRRT Continue Renal Replacement Therapy
Lynda and “Abyle” products
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.
Advanced Adult Intravenous Calculations
Catherine Luksic BSN, RN.  Primary infusion  “maintenance infusion”  “continuous infusion” Via gravity Via electronic pump  Secondary infusion  “piggyback”
Strategies for Improving Adequacy Decreasing the Risk of Premature Death Educate Your Dialysis Team Review Proper Procedure for Drawing Lab Samples - Lab.
Pediatric CRRT: The Dialysis-Centric Program Helen Currier BSN, RN, CNN, CENP Director, Renal & Pheresis Services Texas Children’s Hospital Houston, Texas.
1 CRRT Therapy in the Pediatric Critical Care Patient An overview of common complications and solutions for Pediatric Critical Care Patients undergoing.
Dr Umut Selda Bayrakçı Yıldırım Beyazıt University, Dept of Pediatric Nephrology, Ankara, Turkey * Basics of CRRT Terminology.
Access n If you don’t have it you might as well go home. n This is the most important aspect of CRRT therapy. n Adequacy. n Filter life. n Increased blood.
Management of Infants requiring Venovenous ECMO
Troubleshooting Issues in CVVH Timothy L. Kudelka RN, BSN Pediatric Dialysis Program C.S. Mott Children’s Hospital University of Michigan.
Chapter 19 Critical Care IV Calculations
IV Flow Rates for Titrated Medications (cont.) Goal – to administer the least amount of medication to obtain desired effect Titration is used to adjust.
Matthew L. Paden, MD Division of Pediatric Critical Care
Terminology and Common Issues in Pediatric CRRT John Gardner RN, BSN Nurse Manager Pediatric Nephrology & Transplant DeVos Children’s Hospital Grand Rapids.
Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his.
Pediatric CRRT: The Prescription
ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital.
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
Intravenous Therapy IV Calculations (Math) Sasha A. Rarang, RN, MSN.
What form of anticoagulation is the “best” Or why is Citrate better then Heparin or Prostacyclin.
PCRRT & ECLS Dr. Peter Skippen, PICU. BC Children’s Hospital, Vancouver. CANADA.
Current Technology for CRRT Dr. Peter Skippen, PICU. BC Children’s Hospital, Vancouver. CANADA.
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
Access in Pediatric CRRT
Nursing Issues in Pediatric CRRT
PCRRT PRESCRIPTIONS in ARF Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
Copyright 2008 Society of Critical Care Medicine
Pediatric CRRT Programs: A tool-kit for evaluation Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
David Askenazi MD, MSPH Associate Professor of Pediatrics 2Smaller Circuits for Smaller Patients Improving Renal Support with Aquadex™ Machine.
Brophy University of Iowa Pediatric CRRT Anticoagulation Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital PCRRT.
Citrate Anticoagulation
Vascular Access Considerations and Options for Pediatric CRRT Stuart L. Goldstein, MD.
PCRRT Multi-Center Registry Data Effective April 1, 2002 Multi-Center Pediatric CRRT Registry Stuart L. Goldstein, MD Assistant Professor of Pediatrics.
Vascular Access in CRRT Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Dosing of Anti-Fungal agents on CRRT Timothy E. Bunchman Professor and Director Pediatric Nephrology & Transplantation Children’s Hospital of Richmond.
Cytokine and Soluble Fas Ligand Response in Children with Septic Acute Renal Failure (ARF) on CVVH Paden ML, Fortenberry JD, Rigby MR, Trexler AM, Heard.
Continuous Renal Replacement Therapy Developed by: Critical Care and Hemodialysis Educators, February 2009 King Faisal Specialist Hospital and Research.
Vascular Access The Alpha and Omega of CRRT Rick Hackbarth MD Division of Pediatric Critical Care Grand Rapids, Michigan.
CRRT TERMINOLOGY Stefano Picca, MD
CONTINUOUS RENAL REPLACEMENT THERAPY
CRRT Fundamentals Pre- and Post- Test
Intravenous Therapy IV Calculation (Math)
Access for Pediatric CRRT
Hemodialysis in 20 kg Patient with AKI and Sepsis
Devices use for Neonatal AKI
Prescriptions in CRRT Timothy E Bunchman MD Professor & Director
Pediatric Intravenous Medications
Practical Considerations for CRRT
Nursing Issues in Pediatric CRRT
OUTCOMES OF REGIONAL CITRATE ANTICOAGULATION (RCA) IN PEDIARTIC CONTINUOUS RENAL REPLACEMENT THERAPY (pCRRT) IN A SINGLE CENTER Issa Alhamoud, Diane Gollhofer,
Pediatric CRRT Terminology
Access in Pediatric CRRT
Basics of CRRT: Terminology
Copyright © 2015 NIKKISO Co., LTD. All rights reserved.
Children’s Memorial Hospital Northwestern University
Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.
CRRT dialysis circuit using regional citrate anticoagulation with the Gambro Prisma machine. CRRT dialysis circuit using regional citrate anticoagulation.
1. Volume-Based Feeds: (most patients)
RCA in continuous RRT: basic principles
Pediatric Intravenous Medications
Presentation transcript:

Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan

Complications of Pediatric CRRT b Temperature instability b Hemodynamic instability b Anticoagulation Risk b Circuit/Access Complications

Factors effecting hemodynamics b Patient Volume Status Ultrafiltration RateUltrafiltration Rate –patients hemodynamic –typically vasopressor dependent –patients intravascular volume Ultrafiltration RateUltrafiltration Rate –1-2ml/kg/hour net ultrafiltration –absolute necessity to control ultrafiltration –error of accurate ultrafiltration monitoring

RESULTS (Smoyer et al, CRRT 1997) IV Pump Flow Rate (ml/hr) % Error Trilogy Pump: Accuracy over Range of Flow Rates

Ultrafiltration accuracy 2.8 kg infant on PRISMA Ccs/hr Hour of Therapy Prescription BFR 30 mls/min Dx FR 300 mls/hr

Factors effecting hemodynamics b What now? Hourly assessment of Intake and OutputHourly assessment of Intake and Output Hourly Ultrafiltration calculationsHourly Ultrafiltration calculations – adjusting for pump error Accurate measuring of UltrafiltrationAccurate measuring of Ultrafiltration Close monitoring of hemodynamicsClose monitoring of hemodynamics Accurate daily weightAccurate daily weight

Factors effecting hemodynamics b Calculation for Pump Error

Factors effecting hemodynamics b Vasopressor clearance Vasopressor agents all have in common a small molecular weight and minimal protein bindingVasopressor agents all have in common a small molecular weight and minimal protein binding –Epinephrine –Norepinephrine –Dopamine –Dobutamine

Factors effecting hemodynamics b Vasopressors Due to proximity of infusionDue to proximity of infusion –be aware of infusing vasopressor agents in immediate proximity to the “arterial” port of the hemofiltration machine –potential for recirculation – effects delivery and clearance

Intravascular Blood Volume b < 10 kg 80 ml/kg e.g. 8 kg infant = 640 ml intravascular volumee.g. 8 kg infant = 640 ml intravascular volume b > 10 kg 70 ml/kg e.g. 20 kg child has 1.4 liter intravascular volumeBloode.g. 20 kg child has 1.4 liter intravascular volumeBlood b Priming Hemofiltration Circuit Recommended when circuit volume > 10 % of patients intravascular blood volumeRecommended when circuit volume > 10 % of patients intravascular blood volume

Anticoagulation b Heparin b Citrate b None

Circuit Complications Circuit Complications b Circuit Clotting Inability to ultrafiltrate desired amountInability to ultrafiltrate desired amount Increasing Access/Return PressureIncreasing Access/Return Pressure Inadequate clearancesInadequate clearances Observe clotting in filter/ tubingObserve clotting in filter/ tubing

Clotting with CVVH vs CVVHD (Mottes et al, CRRT 1999)

Flow Rates b Blood 5-10 ml/kg/min keeping venous pressure under 200 mm Hg5-10 ml/kg/min keeping venous pressure under 200 mm Hg b Dialysate/Replacement fluid 2 liters/1.73 m 2 /hr2 liters/1.73 m 2 /hr –(extrapolation of adult data)

Access Complications b What is the correct access? One that worksOne that works

In Flow Difficulties b Obstruction or clot on the return line high intrathoracic pressure with HIFIhigh intrathoracic pressure with HIFI up against the vessel wallup against the vessel wall b Clamp on inflow b Access kinked at skin site b Consider reversing or changing access

Out Flow Difficulties b Clamp on access/”arterial” line b Inflow port up against vessel wall b Patient “dry” eg with femoral site b High of blood flow requirements based upon flow ability of access b Consider reverse flow, change access, decrease blood flow ratesreverse flow, change access, decrease blood flow rates